No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Headquartered in Valbonne, France, Median Technologies S.A. was established in 2002. This company specializes in developing and commercializing advanced software and platforms designed for medical image analysis. Its reach extends globally, serving markets in France, the United States, Canada, the United Kingdom, China, and beyond. Among its key offerings is iBiops, an innovative, AI-powered software classified as a medical device. This solution comprehensively integrates and optimizes the entire medical imaging workflow. Additionally, Median Technologies provides iSee, a service dedicated to image analysis specifically for clinical trials. Furthermore, the company delivers extensive imaging contract research organization (CRO) services. These encompass a wide range of activities, from study initiation and the management of both image and clinical data, to scientific advisory, independent reviews, image data processing, site support, and final study close-out. Solidifying its commitment to research, Median Technologies maintains a collaborative agreement with the University of California.
www.mediantechnologies.comNo one on the platform currently holds ALMDT.PA.
No tracked institution reports a position in ALMDT.PA as of their last filing.
No one on the platform has traded ALMDT.PA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $26M | +12.3% | $-0.44 | $-0.63–$-0.26 | — | 3 |
| 2027 | $35M | +32.2% | $-0.47 | $-0.89–$-0.24 | — | 3 |
| 2028 | $48M | +39.2% | $-0.68 | $-0.74–$-0.62 | — | 1 |
| 2029 | $89M | +84.2% | $-0.24 | $-0.26–$-0.22 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ALMDT.PAMedian Technologies S.A. | $3.60 | -0.83% | $175M | — |
| ABNX.PAABIONYX Pharma S.A. | $1.68 | -0.83% | $71M | — |
| AB.PAAB Science S.A. | $0.71 | -1.88% | $52M | — |
| AFME.PAAffluent Medical S.A. | $2.81 | +0.00% | $110M | — |
| ALCJ.PACrossject S.A. | $1.31 | +0.54% | $79M | — |
| ALECR.PAEurofins-Cerep S.A. | $16100.00 | +0.00% | $81M |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| ALKLH.PAKlea Holding | $0.15 | -4.25% | $47M | — |